CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balances (in shares) at Dec. 31, 2022		29,493,193
Beginning Balances at Dec. 31, 2022	$ 558,393	$ 29,493	$ 387,171	$ 405,167	$ (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	20,807			20,807
Other Comprehensive Income (Loss)	32,946				32,946
Cash Dividends	(7,354)			(7,354)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		80,246
Restricted Share Grants Net	539	$ 80	459
Ending Balances (in shares) at Mar. 31, 2023		29,573,439
Ending Balances at Mar. 31, 2023	$ 605,331	$ 29,573	387,630	418,620	(230,492)
Beginning Balances (in shares) at Dec. 31, 2023	29,584,709	29,584,709
Beginning Balances at Dec. 31, 2023	$ 663,558	$ 29,585	389,411	461,622	(217,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	19,022			19,022
Other Comprehensive Income (Loss)	(19,895)				(19,895)
Cash Dividends	(7,955)			(7,955)
Issuance of Common Stock for:
Restricted Share Grants Net (in shares)		84,310
Restricted Share Grants Net	$ 524	$ 84	440
Ending Balances (in shares) at Mar. 31, 2024	29,669,019	29,669,019
Ending Balances at Mar. 31, 2024	$ 655,254	$ 29,669	$ 389,851	$ 472,689	$ (236,955)